Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis

Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER®, RE-COVER™ II, and RE-MEDY™

(2017) Martin Feuring et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Oral Direct Thrombin Inhibitor as an Alternative in the Management of Cerebral Venous Thrombosis: A Series of 15 Patients

(2015) Marcelo D. Mendonça et al.   International Journal of Stroke

The Heidelberg Bleeding Classification

(2015) Rüdiger von Kummer et al.   STROKE

Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials

(2014) N. van Es et al.   BLOOD

Novel Factor Xa Inhibitor for the Treatment of Cerebral Venous and Sinus Thrombosis

(2014) Christina Geisbüsch et al.   STROKE

The Incidence of Cerebral Venous Thrombosis

(2012) Jonathan M. Coutinho et al.   STROKE

Diagnosis and Management of Cerebral Venous Thrombosis

(2011) Gustavo Saposnik et al.   STROKE

Long-Term Evaluation of the Risk of Recurrence After Cerebral Sinus-Venous Thrombosis

(2010) Ida Martinelli et al.   CIRCULATION

Venous Thromboembolic Events After Cerebral Vein Thrombosis

(2010) Bruno Miranda et al.   STROKE